Full name: chromosome 4 open reading frame 17 | Alias Symbol: DKFZP434G072 | ||
Type: protein-coding gene | Cytoband: 4q23 | ||
Entrez ID: 84103 | HGNC ID: HGNC:25274 | Ensembl Gene: ENSG00000138813 | OMIM ID: |
Drug and gene relationship at DGIdb |
Expression of C4orf17:
Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
---|---|---|---|---|---|---|
GSE17351 | C4orf17 | 84103 | 223990_at | -0.0150 | 0.9661 | |
GSE26886 | C4orf17 | 84103 | 223990_at | -0.1323 | 0.1806 | |
GSE45670 | C4orf17 | 84103 | 223990_at | 0.0335 | 0.7696 | |
GSE53622 | C4orf17 | 84103 | 10174 | 0.0498 | 0.6943 | |
GSE53624 | C4orf17 | 84103 | 10174 | 0.3284 | 0.0024 | |
GSE63941 | C4orf17 | 84103 | 223990_at | 0.3846 | 0.0098 | |
GSE77861 | C4orf17 | 84103 | 223990_at | 0.0649 | 0.4814 | |
TCGA | C4orf17 | 84103 | RNAseq | 3.3427 | 0.0106 |
Upregulated datasets: 1; Downregulated datasets: 0.
Survival by C4orf17 expression:
Note: Click image to view full size file.
Copy number change of C4orf17:
Dataset | Gene | EntrezID | Gain | Loss | Normal | Detail |
---|---|---|---|---|---|---|
GSE15526 | C4orf17 | 84103 | 0 | 12 | 18 | |
GSE20123 | C4orf17 | 84103 | 0 | 12 | 18 | |
GSE43470 | C4orf17 | 84103 | 0 | 13 | 30 | |
GSE46452 | C4orf17 | 84103 | 1 | 36 | 22 | |
GSE47630 | C4orf17 | 84103 | 0 | 20 | 20 | |
GSE54993 | C4orf17 | 84103 | 9 | 0 | 61 | |
GSE54994 | C4orf17 | 84103 | 1 | 11 | 41 | |
GSE60625 | C4orf17 | 84103 | 0 | 3 | 8 | |
GSE74703 | C4orf17 | 84103 | 0 | 11 | 25 | |
GSE74704 | C4orf17 | 84103 | 0 | 6 | 14 | |
TCGA | C4orf17 | 84103 | 8 | 40 | 48 |
Total number of gains: 19; Total number of losses: 164; Total Number of normals: 305.
Somatic mutations of C4orf17:
Generating mutation plots.
Highly correlated genes for C4orf17:
Showing top 20/108 corelated genes with mean PCC>0.5.
Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
---|---|---|---|---|---|
C4orf17 | PRB1 | 0.72642 | 3 | 0 | 3 |
C4orf17 | UTS2R | 0.712368 | 3 | 0 | 3 |
C4orf17 | KIR2DS2 | 0.666368 | 3 | 0 | 3 |
C4orf17 | NFIA-AS2 | 0.665168 | 3 | 0 | 3 |
C4orf17 | LILRB1 | 0.660636 | 3 | 0 | 3 |
C4orf17 | MAP3K19 | 0.658892 | 3 | 0 | 3 |
C4orf17 | LINC01304 | 0.656122 | 3 | 0 | 3 |
C4orf17 | DRD2 | 0.652298 | 4 | 0 | 3 |
C4orf17 | EXOC3L2 | 0.650179 | 4 | 0 | 3 |
C4orf17 | SLC4A1 | 0.648907 | 3 | 0 | 3 |
C4orf17 | UROC1 | 0.648167 | 3 | 0 | 3 |
C4orf17 | CACNB1 | 0.64247 | 3 | 0 | 3 |
C4orf17 | PRKAR1B | 0.640858 | 3 | 0 | 3 |
C4orf17 | APOA5 | 0.635968 | 3 | 0 | 3 |
C4orf17 | APOBEC3D | 0.63479 | 3 | 0 | 3 |
C4orf17 | STAC2 | 0.628394 | 4 | 0 | 4 |
C4orf17 | C2orf72 | 0.62352 | 4 | 0 | 3 |
C4orf17 | TMEM105 | 0.61208 | 3 | 0 | 3 |
C4orf17 | KLF16 | 0.611462 | 3 | 0 | 3 |
C4orf17 | BCAN | 0.611307 | 4 | 0 | 4 |
For details and further investigation, click here